Assessing Success of MTA and Pre-mixed Bioceramic in Mature Teeth With Irreversible Pulpitis With Full Pulpotomy.
Status:
Completed
Trial end date:
2022-08-30
Target enrollment:
Participant gender:
Summary
Although many pulpotomy agents are commercially available, there is a dearth of clinical
research comparing the efficacy of these agents in treating individuals with irreversible
pulpitis. Bioceramic and MTA both have similar clinical uses, but Bioceramic is distinguished
from MTA by its superior chemical, physical, and biological properties. This study aims to
address this knowledge deficit by assessing the performance of biocompatible materials in
pulpotomy procedures for the treatment of symptomatic permanent teeth in adults with deep
caries. For permanent teeth with a completed root and a diagnosis of irreversible pulpitis
without apical periodontitis, this research will compare the success rates of MTA and EBRRM
pulpotomy procedures in order to provide evidence-based clinical practice guidelines for the
treatment of this disease.